A report on the latest news relating to heart failure treatment options and study findings.
The Clinical Services Journal reports on the latest news relating to heart failure treatment options and study findings which were discussed at the annual European Society of Cardiology (ESC) Congress, recently held in London.
Despite advances in therapy, morbidity and mortality from heart failure (HF) remain high, with five-year mortality rates exceeding 50%.1 Several presentations at the recent ESC Congress looked at the latest devices and biomaterials that are creating alternative treatment options for some HF patients.
Gerd Hasenfuss, from the Heart Centre of Göttingen in Germany, for example, described how cardiac contractility modulation (CCM) devices are being used to enhance natural contractions of the heart.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
